만성질환 관리 시장 규모, 점유율, 성장 분석 : 질환 유형별, 관리 유형별, 최종 용도별, 기술별, 지역별 - 업계 예측(2026-2033년)

Global Chronic Disease Management Market size was valued at USD 6.98 Billion in 2024 and is poised to grow from USD 8 Billion in 2025 to USD 23.63 Billion by 2033, growing at a CAGR of 14.5% during the forecast period (2026-2033).

The global chronic disease management market is experiencing significant growth, driven by the rising prevalence of chronic diseases, particularly in urban areas due to shifting lifestyle patterns. Increasing internet penetration has enhanced health awareness, facilitating wider access to telemedicine and healthcare information, which amplifies demand for chronic disease management solutions. The surge in urban air pollution is also contributing to a rise in respiratory illnesses, further fueling this demand. Additionally, the aging population, more vulnerable to long-term conditions, represents a substantial patient base. Moreover, corporate investment in employee health through wellness programs is accelerating market growth, as organizations recognize the importance of chronic disease management in maintaining workforce productivity and overall well-being.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Chronic Disease Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Chronic Disease Management Market Segments Analysis

Global Chronic Disease Management Market is segmented by Disease Type, Management Type, End Use, Technology and region. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular Diseases, Chronic Respiratory Diseases, Cancer and Chronic Kidney Diseases. Based on Management Type, the market is segmented into Lifestyle Management, Medication Management, Telehealth Services, Patient Education and Monitoring Services. Based on End Use, the market is segmented into Healthcare Providers, Patients, Pharmaceutical Companies, Insurance Companies and Research Organizations. Based on Technology, the market is segmented into Wearable Devices, Mobile Applications, Cloud Computing, Electronic Health Records and Telemedicine. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Chronic Disease Management Market

The surge in digitalization is revolutionizing health management by providing individuals with accessible real-time monitoring tools that enhance their awareness of personal health. The growth of the chronic disease management market is significantly driven by the emergence of smartwatches and fitness trackers, which allow users to continuously monitor vital signs such as blood pressure and heart rate. This technology empowers individuals to stay informed about their physical condition, prompting them to seek medical advice when necessary. As a result, there is an increase in healthcare visits, with patients prioritizing fitness and overall wellness in their daily lives.

Restraints in the Global Chronic Disease Management Market

While technological advancements in healthcare significantly enhance management of chronic diseases in developed economies, several factors continue to pose challenges to the growth of the global chronic disease management market. In lower-income regions, budget limitations hinder the adoption of innovative technologies within healthcare systems, resulting in suboptimal medical outcomes. This disparity in access to advanced treatment options and resources not only affects patient care but also slows the overall progress of chronic disease management initiatives worldwide. Consequently, addressing these economic constraints remains crucial for improving health outcomes in affected areas and fostering a more equitable healthcare landscape.

Market Trends of the Global Chronic Disease Management Market

The global chronic disease management market is experiencing significant growth, driven by the rising adoption of telemedicine and advanced remote monitoring technologies. This trend is transforming the clinical management of chronic diseases, allowing patients, especially those in underserved or rural areas, to access healthcare services conveniently from their homes. The capability of healthcare providers to remotely monitor symptoms and health indicators facilitates timely interventions, leading to improved health outcomes and enhanced quality of care. As more healthcare systems integrate these technologies into their practices, the market reflects a shift towards more patient-centered, efficient, and accessible chronic disease management solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Chronic Disease Management Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Diabetes
• Cardiovascular Diseases
• Chronic Respiratory Diseases
• Cancer
• Chronic Kidney Diseases

Global Chronic Disease Management Market Size by Management Type & CAGR (2026-2033)

• Market Overview
• Lifestyle Management
• Medication Management
• Telehealth Services
• Patient Education
• Monitoring Services

Global Chronic Disease Management Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Healthcare Providers
• Patients
• Pharmaceutical Companies
• Insurance Companies
• Research Organizations

Global Chronic Disease Management Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Wearable Devices
• Mobile Applications
• Cloud Computing
• Electronic Health Records
• Telemedicine

Global Chronic Disease Management Market Size & CAGR (2026-2033)

• North America (Disease Type, Management Type, End Use, Technology)
  • US
  • Canada
• Europe (Disease Type, Management Type, End Use, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Disease Type, Management Type, End Use, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Disease Type, Management Type, End Use, Technology)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Disease Type, Management Type, End Use, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Optum, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognizant (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infosys Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EXL Service Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WellSky (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZeOmega (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Catalyst (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pegasystems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humana Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teladoc Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChartSpan (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Signallamp Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Engooden Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optimize Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations